Compare KraneShares Electric Vehicles and Future Mobility (KARS) vs Moderna, Inc. (MRNA) Price & Performance

KraneShares Electric Vehicles and Future MobilityTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

KraneShares Electric Vehicles and Future Mobility vs Moderna, Inc. — how do they compare? KraneShares Electric Vehicles and Future Mobility trades at $29.85, while Moderna, Inc. trades at $59.68 (market cap $23.60B). The key difference: Moderna, Inc. is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.

	KARS	MRNA
Sector	Sector/Thematic	Health
52-Week High	$38.01	$81.80
52-Week Low	$23.61	$22.36
Market Cap	—	$23.60B
Enterprise Value	—	$19.70B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KARS

View details →

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About KraneShares Electric Vehicles and Future Mobility

KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.